Traveller vaccination tuberculosis: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Traveller vaccination | {{Traveller vaccination}} | ||
{{CMG}};{{AE}}{{USAMA}} | {{CMG}};{{AE}}{{USAMA}} | ||
==Overview== | ==Overview== | ||
Vaccination of young children against tuberculosis is not specific to the needs of travellers. In many countries BCG-vaccination of newborns and infants is routinely administered. Unvaccinated young children who are brought to an environment of high prevalence for tuberculosis should be offered vaccination according to the respective national recommendations. | Vaccination of young children against [[tuberculosis]] is not specific to the needs of travellers. In many countries [[BCG]]-vaccination of newborns and infants is routinely administered. Unvaccinated young children who are brought to an environment of high prevalence for tuberculosis should be offered vaccination according to the respective national recommendations. | ||
==Disease cause== | ==Disease cause== | ||
The tubercle bacillus Mycobacterium tuberculosis. | The tubercle bacillus [[Mycobacterium tuberculosis]]. | ||
==Transmission== | ==Transmission== | ||
| Line 12: | Line 12: | ||
==Nature of the disease== | ==Nature of the disease== | ||
In most cases, exposure to M. tuberculosis results in latent infection, which only occasionally turns into active disease. Tuberculosis may affect any organ but, from a public health point of view, active pulmonary disease with mycobacterial dissemination is the most important manifestation. In infants, tuberculous meningitis or disseminated disease may occur. Multidrug-resistance of M. tuberculosis is a rapidly increasing problem. | In most cases, exposure to [[Mycobacterium tuberculosis|M. tuberculosis]] results in latent infection, which only occasionally turns into active disease. [[Tuberculosis]] may affect any organ but, from a public health point of view, active pulmonary disease with mycobacterial dissemination is the most important manifestation. In infants, [[tuberculous meningitis]] or disseminated disease may occur. Multidrug-resistance of M. tuberculosis is a rapidly increasing problem. | ||
==Geographical distribution== | ==Geographical distribution== | ||
Worldwide among deprived populations, but most common in poor countries | Worldwide among deprived populations, but most common in poor countries. Tuberculosis is highly prevalent among [[HIV]] infected individuals. | ||
[[image:TB-1.jpg]] | |||
<br clear="left"/> | |||
==Risk for travellers== | ==Risk for travellers== | ||
Most travellers are at low risk for tuberculosis. On the other hand, for those coming from countries where its endemicity is low to work in, for example, emergency relief in countries highly endemic for tuberculosis the risk may be considerable. Individuals with HIV infection are particularly susceptible. | Most travellers are at low risk for tuberculosis. On the other hand, for those coming from countries where its endemicity is low to work in, for example, emergency relief in countries highly endemic for tuberculosis the risk may be considerable. Individuals with [[HIV]] infection are particularly susceptible. | ||
==Vaccine== | ==Vaccine== | ||
BCG vaccines are based on live attenuated mycobacterial strains descended from the original, attenuated bacillus | [[BCG vaccine|BCG vaccines]] are based on live attenuated [[mycobacterial]] strains descended from the original, attenuated bacillus Calmette Guérin. Apart from its documented effect against tuberculous meningitis and disseminated disease in infants, BCG vaccination is of very limited value for most travellers. | ||
==Precautions== | ==Precautions== | ||
Where possible, travellers should avoid prolonged and close contact with people with known or suspected cases of pulmonary tuberculosis. A tuberculin skin test before and after a high-risk mission abroad may be advisable for example for health professionals and humanitarian relief workers. | Where possible, travellers should avoid prolonged and close contact with people with known or suspected cases of [[pulmonary tuberculosis]]. A [[tuberculin skin test]] before and after a high-risk mission abroad may be advisable for example for health professionals and humanitarian relief workers. | ||
Latest revision as of 15:44, 21 April 2017
|
Traveler Vaccination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Overview
Vaccination of young children against tuberculosis is not specific to the needs of travellers. In many countries BCG-vaccination of newborns and infants is routinely administered. Unvaccinated young children who are brought to an environment of high prevalence for tuberculosis should be offered vaccination according to the respective national recommendations.
Disease cause
The tubercle bacillus Mycobacterium tuberculosis.
Transmission
By inhalation of M. tuberculosis-containing microscopic droplets.
Nature of the disease
In most cases, exposure to M. tuberculosis results in latent infection, which only occasionally turns into active disease. Tuberculosis may affect any organ but, from a public health point of view, active pulmonary disease with mycobacterial dissemination is the most important manifestation. In infants, tuberculous meningitis or disseminated disease may occur. Multidrug-resistance of M. tuberculosis is a rapidly increasing problem.
Geographical distribution
Worldwide among deprived populations, but most common in poor countries. Tuberculosis is highly prevalent among HIV infected individuals.
Risk for travellers
Most travellers are at low risk for tuberculosis. On the other hand, for those coming from countries where its endemicity is low to work in, for example, emergency relief in countries highly endemic for tuberculosis the risk may be considerable. Individuals with HIV infection are particularly susceptible.
Vaccine
BCG vaccines are based on live attenuated mycobacterial strains descended from the original, attenuated bacillus Calmette Guérin. Apart from its documented effect against tuberculous meningitis and disseminated disease in infants, BCG vaccination is of very limited value for most travellers.
Precautions
Where possible, travellers should avoid prolonged and close contact with people with known or suspected cases of pulmonary tuberculosis. A tuberculin skin test before and after a high-risk mission abroad may be advisable for example for health professionals and humanitarian relief workers.